AVITA Medical (NASDAQ:RCEL) just reported results for the second quarter of 2024.
- AVITA Medical reported earnings per share of -60 cents. This was below the analyst estimate for EPS of -52 cents.
- The company reported revenue of $15.20 million.
- This was 3.16% better than the analyst estimate for revenue of $14.73 million.